Related references
Note: Only part of the references are listed.The value of completion axillary treatment in sentinel node positive breast cancer patients undergoing a mastectomy: a Dutch randomized controlled multicentre trial (BOOG 2013-07)
L. M. van Roozendaal et al.
BMC CANCER (2015)
POSNOC: A Randomised Trial Looking at Axillary Treatment in Women with One or Two Sentinel Nodes with Macrometastases
A. Goyal et al.
CLINICAL ONCOLOGY (2015)
Impact of the American College of Surgeons Oncology Group Z0011 Randomized Trial on the Number of Axillary Nodes Removed for Patients with Early-Stage Breast Cancer
Katharine Yao et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2015)
Regional Nodal Irradiation in Early-Stage Breast Cancer
Timothy J. Whelan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer
P. M. Poortmans et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Axillary Dissection Can Be Avoided in the Majority of Clinically Node-Negative Patients Undergoing Breast-Conserving Therapy
Lynn T. Dengel et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Radiation Field Design in the ACOSOG Z0011 (Alliance) Trial
Reshma Jagsi et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials
P. McGale et al.
LANCET (2014)
Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial
Mila Donker et al.
LANCET ONCOLOGY (2014)
Evolution of sites of recurrence after early breast cancer over the last 20 years: implications for patient care and future research
N. Bouganim et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial
Viviana Galimberti et al.
LANCET ONCOLOGY (2013)
Characteristics and Outcomes of Sentinel Node-Positive Breast Cancer Patients after Total Mastectomy without Axillary-Specific Treatment
Sarah Milgrom et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype
Aoife J. Lowery et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Predictors of Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From Combined Analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27
Eleftherios P. Mamounas et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
The False-Negative Rate of Sentinel Node Biopsy in Patients with Breast Cancer: A Meta-Analysis
Sarah Pesek et al.
WORLD JOURNAL OF SURGERY (2012)
Sentinel lymph node biopsy compared with axillary lymph node dissection in early breast cancer: a meta-analysis
Zhen Wang et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis A Randomized Clinical Trial
Armando E. Giuliano et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Outcome of axillary staging in early breast cancer: a meta-analysis
Malcolm R. Kell et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Association Between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor-Positive Breast Cancer: Results From NSABP B-14 and NSABP B-20
Eleftherios P. Mamounas et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Comparison of Sentinel Lymph Node Biopsy Alone and Completion Axillary Lymph Node Dissection for Node-Positive Breast Cancer
Karl Y. Bilimoria et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: A systematic review and meta-analysis of the literature
I. M. C. van der Ploeg et al.
EJSO (2008)
Trastuzumab in the adjuvant treatment of early-stage breast cancer: A systematic review and meta-analysis of randomized controlled trials
Issa J. Dahabreh et al.
ONCOLOGIST (2008)
Share Paper
